Literature DB >> 24429902

Etiology and pathogenesis of late-onset Alzheimer's disease.

Brian J Balin1, Alan P Hudson.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative condition that occurs in two forms, an early-onset form that is genetically determined and a far more common late-onset form that is not. In both cases, the disease results in severe cognitive dysfunction, among other problems, and the late-onset form of the disease is now considered to be the most common cause of dementia among the elderly. While a good deal of research has been focused on elucidating the etiology of the late-onset form for more than two decades, results to date have been modest and have not yet engendered useful therapeutic strategies for cure of the disease. In this review, we discuss the prevalent ideas that have governed this research for several years, and we challenge these ideas with alternative findings suggesting a multifactorial etiology. We review promising newer ideas that may prove effective as therapeutic interventions for late-onset AD, as well as providing reliable means of earlier and more specific diagnosis of the disease process. In the discussions included here, we reference relevant clinical and basic science literature underlying research into disease etiology and pathogenesis, and we highlight current reviews on the various topics addressed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24429902     DOI: 10.1007/s11882-013-0417-1

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  109 in total

1.  Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease.

Authors:  D Nochlin; C M Shaw; L A Campbell; C C Kuo
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

Review 2.  The amyloid hypothesis: let sleeping dogmas lie?

Authors:  Glenda M Bishop; Stephen R Robinson
Journal:  Neurobiol Aging       Date:  2002 Nov-Dec       Impact factor: 4.673

Review 3.  Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system.

Authors:  Gabriel A Silva
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

Review 4.  Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.

Authors:  David Prvulovic; Harald Hampel
Journal:  Clin Chem Lab Med       Date:  2011-02-23       Impact factor: 3.694

5.  Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.

Authors:  Richard E Hartman; Helmut Laurer; Luca Longhi; Kelly R Bales; Steven M Paul; Tracy K McIntosh; David M Holtzman
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

Review 6.  The interaction of amyloid-beta with ApoE.

Authors:  Donald B Carter
Journal:  Subcell Biochem       Date:  2005

7.  Ibuprofen inhibits the synaptic failure induced by the amyloid-β peptide in hippocampal neurons.

Authors:  Maria Paz Zurita; Gonzalo Muñoz; Fernando J Sepúlveda; Paulina Gómez; Carolina Castillo; Carlos F Burgos; Jorge Fuentealba; Carlos Opazo; Luis G Aguayo
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Alzheimer's disease--a spirochetosis?

Authors:  J Miklossy
Journal:  Neuroreport       Date:  1993-07       Impact factor: 1.837

9.  Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms.

Authors:  J M Ordovas; L Litwack-Klein; P W Wilson; M M Schaefer; E J Schaefer
Journal:  J Lipid Res       Date:  1987-04       Impact factor: 5.922

10.  Galactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's disease.

Authors:  Jonathan D Cherry; Bin Liu; Jeffrey L Frost; Cynthia A Lemere; Jacqueline P Williams; John A Olschowka; M Kerry O'Banion
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  22 in total

Review 1.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

Review 2.  Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.

Authors:  Jessay Gopuran Devassy; Shan Leng; Melissa Gabbs; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

3.  Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts.

Authors:  Mary Alice Allnutt; Kory Johnson; David A Bennett; Sarah M Connor; Juan C Troncoso; Olga Pletnikova; Marilyn S Albert; Susan M Resnick; Sonja W Scholz; Philip L De Jager; Steven Jacobson
Journal:  Neuron       Date:  2020-01-23       Impact factor: 17.173

4.  Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease.

Authors:  Anna Kruyer; Nadine Soplop; Sidney Strickland; Erin H Norris
Journal:  Hypertension       Date:  2015-05-04       Impact factor: 10.190

5.  Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease.

Authors:  Zhong-Yuan Yu; Wei-Wei Li; Hai-Mei Yang; Noralyn B Mañucat-Tan; Jun Wang; Ye-Ran Wang; Bin-Lu Sun; Zi-Cheng Hu; Li-Li Zhang; Liang Tan; Juan Deng; Yu-Hui Liu
Journal:  Neurotox Res       Date:  2020-02-05       Impact factor: 3.911

Review 6.  Brain Under Stress and Alzheimer's Disease.

Authors:  Boris Mravec; Lubica Horvathova; Alexandra Padova
Journal:  Cell Mol Neurobiol       Date:  2017-07-11       Impact factor: 5.046

7.  miR-133b is a potential diagnostic biomarker for Alzheimer's disease and has a neuroprotective role.

Authors:  Qin Yang; Qiuling Zhao; Yanliang Yin
Journal:  Exp Ther Med       Date:  2019-08-05       Impact factor: 2.447

8.  Metforminium Decavanadate (MetfDeca) Treatment Ameliorates Hippocampal Neurodegeneration and Recognition Memory in a Metabolic Syndrome Model.

Authors:  Alfonso Diaz; Guadalupe Muñoz-Arenas; Berenice Venegas; Rubén Vázquez-Roque; Gonzalo Flores; Jorge Guevara; Enrique Gonzalez-Vergara; Samuel Treviño
Journal:  Neurochem Res       Date:  2021-02-09       Impact factor: 3.996

Review 9.  Microbes and Alzheimer's Disease.

Authors:  Ruth F Itzhaki; Richard Lathe; Brian J Balin; Melvyn J Ball; Elaine L Bearer; Heiko Braak; Maria J Bullido; Chris Carter; Mario Clerici; S Louise Cosby; Kelly Del Tredici; Hugh Field; Tamas Fulop; Claudio Grassi; W Sue T Griffin; Jürgen Haas; Alan P Hudson; Angela R Kamer; Douglas B Kell; Federico Licastro; Luc Letenneur; Hugo Lövheim; Roberta Mancuso; Judith Miklossy; Carola Otth; Anna Teresa Palamara; George Perry; Christopher Preston; Etheresia Pretorius; Timo Strandberg; Naji Tabet; Simon D Taylor-Robinson; Judith A Whittum-Hudson
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

10.  Can oral infection be a risk factor for Alzheimer's disease?

Authors:  Ingar Olsen; Sim K Singhrao
Journal:  J Oral Microbiol       Date:  2015-09-17       Impact factor: 5.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.